64Cu-SAR-BBN for Identification of Participants With Recurrence of Prostate Cancer (SABRE)

NCT05407311 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Biochemical Recurrence of Malignant Neoplasm of Prostate

Interventions

DRUG: 64Cu-SAR-BBN

Sponsor

Clarity Pharmaceuticals Ltd